<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clinical Proteomics - Enhanced</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 40px 20px;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            padding: 45px;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }
        .title {
            font-size: 32px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 35px;
            text-align: center;
            border-bottom: 3px solid #1E64C8;
            padding-bottom: 15px;
        }
        .content-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 25px;
            margin-bottom: 50px;
        }
        .content-card {
            background: #f8fbff;
            border-left: 4px solid #1E64C8;
            padding: 20px 25px;
            border-radius: 6px;
            transition: all 0.3s;
        }
        .content-card:hover {
            background: #e8f2ff;
            transform: translateX(5px);
        }
        .card-title {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 12px;
        }
        .card-content {
            font-size: 16px;
            color: #333;
            line-height: 1.6;
        }
        .bullet {
            display: flex;
            align-items: flex-start;
            margin-bottom: 8px;
        }
        .bullet::before {
            content: "•";
            color: #1E64C8;
            font-weight: bold;
            margin-right: 10px;
            font-size: 18px;
        }
        
        /* Detailed Sections */
        .detailed-section {
            margin-bottom: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 10px;
            border: 2px solid #e0e0e0;
        }
        .section-header {
            font-size: 26px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
        }
        .section-number {
            background: #1E64C8;
            color: white;
            width: 40px;
            height: 40px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 15px;
            font-size: 20px;
        }
        .section-content {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
            margin-top: 20px;
        }
        .diagram {
            background: white;
            padding: 20px;
            border-radius: 8px;
            border: 2px solid #1E64C8;
            min-height: 300px;
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
        }
        .description {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
        }
        .description h3 {
            color: #1E64C8;
            font-size: 18px;
            margin-bottom: 12px;
            margin-top: 15px;
        }
        .description ul {
            margin-left: 20px;
            margin-top: 10px;
        }
        .description li {
            margin-bottom: 8px;
        }
        
        /* SVG Diagram Styles */
        .svg-container {
            width: 100%;
            height: 100%;
            display: flex;
            align-items: center;
            justify-content: center;
        }
        svg {
            max-width: 100%;
            height: auto;
        }
        .svg-text {
            font-family: Aptos, 'Segoe UI', sans-serif;
            font-size: 12px;
            fill: #333;
        }
        .svg-title {
            font-family: Aptos, 'Segoe UI', sans-serif;
            font-size: 14px;
            font-weight: 600;
            fill: #1E64C8;
        }
        .arrow {
            stroke: #1E64C8;
            stroke-width: 2;
            fill: none;
            marker-end: url(#arrowhead);
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Clinical Proteomics</div>
        
        <!-- Overview Grid -->
        <div class="content-grid">
            <div class="content-card">
                <div class="card-title">Biomarker Discovery</div>
                <div class="card-content">
                    <div class="bullet">Disease-specific proteins</div>
                    <div class="bullet">Early detection markers</div>
                    <div class="bullet">Prognostic indicators</div>
                </div>
            </div>
            
            <div class="content-card">
                <div class="card-title">Plasma Proteomics</div>
                <div class="card-content">
                    <div class="bullet">High dynamic range challenge</div>
                    <div class="bullet">Depletion strategies</div>
                    <div class="bullet">Abundant protein removal</div>
                </div>
            </div>
            
            <div class="content-card">
                <div class="card-title">Tissue Proteomics</div>
                <div class="card-content">
                    <div class="bullet">FFPE sample analysis</div>
                    <div class="bullet">Spatial proteomics</div>
                    <div class="bullet">Disease pathology</div>
                </div>
            </div>
            
            <div class="content-card">
                <div class="card-title">FDA-Approved Tests</div>
                <div class="card-content">
                    <div class="bullet">MALDI-TOF bacterial ID</div>
                    <div class="bullet">Targeted protein panels</div>
                    <div class="bullet">Clinical validation requirements</div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 1: Biomarker Discovery -->
        <div class="detailed-section">
            <div class="section-header">
                <span class="section-number">1</span>
                Biomarker Discovery in Detail
            </div>
            <div class="section-content">
                <div class="diagram">
                    <svg width="400" height="350" viewBox="0 0 400 350">
                        <defs>
                            <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                                <polygon points="0 0, 10 3, 0 6" fill="#1E64C8" />
                            </marker>
                        </defs>
                        
                        <!-- Discovery Pipeline -->
                        <rect x="50" y="30" width="120" height="50" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="110" y="60" class="svg-text" text-anchor="middle">Sample Collection</text>
                        
                        <line x1="110" y1="80" x2="110" y2="110" class="arrow"/>
                        
                        <rect x="50" y="110" width="120" height="50" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="110" y="140" class="svg-text" text-anchor="middle">Mass Spec Analysis</text>
                        
                        <line x1="110" y1="160" x2="110" y2="190" class="arrow"/>
                        
                        <rect x="50" y="190" width="120" height="50" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="110" y="220" class="svg-text" text-anchor="middle">Statistical Analysis</text>
                        
                        <line x1="110" y1="240" x2="110" y2="270" class="arrow"/>
                        
                        <rect x="40" y="270" width="140" height="50" fill="#1E64C8" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="110" y="300" class="svg-title" text-anchor="middle" fill="white">Biomarker</text>
                        <text x="110" y="315" class="svg-text" text-anchor="middle" fill="white">Candidates</text>
                        
                        <!-- Types of Biomarkers -->
                        <rect x="230" y="50" width="150" height="40" fill="#fff4e6" stroke="#ff9800" stroke-width="2" rx="5"/>
                        <text x="305" y="75" class="svg-text" text-anchor="middle">Diagnostic</text>
                        
                        <rect x="230" y="110" width="150" height="40" fill="#e8f5e9" stroke="#4caf50" stroke-width="2" rx="5"/>
                        <text x="305" y="135" class="svg-text" text-anchor="middle">Prognostic</text>
                        
                        <rect x="230" y="170" width="150" height="40" fill="#fce4ec" stroke="#e91e63" stroke-width="2" rx="5"/>
                        <text x="305" y="195" class="svg-text" text-anchor="middle">Predictive</text>
                        
                        <rect x="230" y="230" width="150" height="40" fill="#f3e5f5" stroke="#9c27b0" stroke-width="2" rx="5"/>
                        <text x="305" y="255" class="svg-text" text-anchor="middle">Monitoring</text>
                    </svg>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Biomarker discovery is the process of identifying measurable indicators of biological states or conditions. In clinical proteomics, this involves detecting disease-specific proteins that can serve as diagnostic, prognostic, or therapeutic markers.</p>
                    
                    <h3>Key Applications</h3>
                    <ul>
                        <li><strong>Disease-specific proteins:</strong> Identification of proteins uniquely expressed or altered in disease states (e.g., PSA for prostate cancer, troponin for cardiac events)</li>
                        <li><strong>Early detection markers:</strong> Discovery of proteins that appear before clinical symptoms, enabling preventive intervention</li>
                        <li><strong>Prognostic indicators:</strong> Proteins that predict disease progression, patient survival, or treatment outcomes</li>
                    </ul>
                    
                    <h3>Workflow</h3>
                    <ul>
                        <li>Comparative analysis between disease and control samples</li>
                        <li>High-throughput mass spectrometry screening</li>
                        <li>Bioinformatics analysis for candidate selection</li>
                        <li>Validation in independent cohorts</li>
                        <li>Clinical utility assessment</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Detailed Section 2: Plasma Proteomics -->
        <div class="detailed-section">
            <div class="section-header">
                <span class="section-number">2</span>
                Plasma Proteomics in Detail
            </div>
            <div class="section-content">
                <div class="diagram">
                    <svg width="400" height="350" viewBox="0 0 400 350">
                        <!-- Dynamic Range Visualization -->
                        <text x="200" y="25" class="svg-title" text-anchor="middle">Protein Abundance Range</text>
                        
                        <!-- High abundance proteins -->
                        <rect x="50" y="50" width="100" height="80" fill="#ff5252" stroke="#c62828" stroke-width="2" rx="5"/>
                        <text x="100" y="85" class="svg-text" text-anchor="middle" fill="white">Albumin</text>
                        <text x="100" y="105" class="svg-text" text-anchor="middle" fill="white">55% of</text>
                        <text x="100" y="120" class="svg-text" text-anchor="middle" fill="white">total protein</text>
                        
                        <rect x="160" y="50" width="80" height="80" fill="#ff7043" stroke="#d84315" stroke-width="2" rx="5"/>
                        <text x="200" y="85" class="svg-text" text-anchor="middle" fill="white">IgG</text>
                        <text x="200" y="105" class="svg-text" text-anchor="middle" fill="white">~15%</text>
                        
                        <!-- Medium abundance -->
                        <rect x="250" y="60" width="60" height="70" fill="#ffa726" stroke="#ef6c00" stroke-width="2" rx="5"/>
                        <text x="280" y="95" class="svg-text" text-anchor="middle">Other</text>
                        <text x="280" y="110" class="svg-text" text-anchor="middle">abundant</text>
                        
                        <!-- Low abundance -->
                        <rect x="320" y="80" width="40" height="50" fill="#66bb6a" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="340" y="105" class="svg-text" text-anchor="middle" font-size="10">Biomarkers</text>
                        
                        <!-- Concentration scale -->
                        <line x1="50" y1="160" x2="360" y2="160" stroke="#333" stroke-width="1"/>
                        <text x="50" y="180" class="svg-text" font-size="10">10¹⁰ mg/L</text>
                        <text x="340" y="180" class="svg-text" font-size="10">10⁻² mg/L</text>
                        <text x="200" y="195" class="svg-text" text-anchor="middle" font-style="italic">12 orders of magnitude</text>
                        
                        <!-- Depletion Strategy -->
                        <text x="200" y="230" class="svg-title" text-anchor="middle">Depletion Strategy</text>
                        
                        <circle cx="80" cy="260" r="25" fill="#ff5252" stroke="#c62828" stroke-width="2"/>
                        <text x="80" y="265" class="svg-text" text-anchor="middle" fill="white">Before</text>
                        
                        <line x1="105" y1="260" x2="145" y2="260" class="arrow"/>
                        
                        <rect x="145" y="240" width="70" height="40" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2" rx="5"/>
                        <text x="180" y="265" class="svg-text" text-anchor="middle" font-size="11">Depletion</text>
                        
                        <line x1="215" y1="260" x2="255" y2="260" class="arrow"/>
                        
                        <circle cx="290" cy="260" r="25" fill="#66bb6a" stroke="#2e7d32" stroke-width="2"/>
                        <text x="290" y="265" class="svg-text" text-anchor="middle" fill="white">After</text>
                        
                        <text x="200" y="310" class="svg-text" text-anchor="middle">Enhanced detection of low-abundance proteins</text>
                    </svg>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Plasma proteomics presents unique challenges due to the extraordinary dynamic range of protein concentrations, spanning more than 10 orders of magnitude. A few highly abundant proteins (albumin, immunoglobulins) constitute over 90% of total protein mass, masking clinically relevant low-abundance biomarkers.</p>
                    
                    <h3>Challenges</h3>
                    <ul>
                        <li><strong>High dynamic range:</strong> Albumin alone accounts for ~55% of plasma protein, while important biomarkers may exist at pg/mL concentrations</li>
                        <li><strong>Sample complexity:</strong> Over 10,000 different proteins estimated in human plasma</li>
                        <li><strong>Detection sensitivity:</strong> Most mass spectrometers cannot detect low-abundance proteins without enrichment</li>
                    </ul>
                    
                    <h3>Depletion Strategies</h3>
                    <ul>
                        <li><strong>Immunoaffinity depletion:</strong> Antibody-based removal of top 6-20 abundant proteins</li>
                        <li><strong>Combinatorial peptide ligand libraries:</strong> Equalizes protein concentrations</li>
                        <li><strong>Fractionation techniques:</strong> Size exclusion, ion exchange, hydrophobic interaction chromatography</li>
                        <li>Trade-off: Risk of losing bound biomarkers during depletion</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Detailed Section 3: Tissue Proteomics -->
        <div class="detailed-section">
            <div class="section-header">
                <span class="section-number">3</span>
                Tissue Proteomics in Detail
            </div>
            <div class="section-content">
                <div class="diagram">
                    <svg width="400" height="350" viewBox="0 0 400 350">
                        <!-- FFPE Process -->
                        <text x="200" y="25" class="svg-title" text-anchor="middle">FFPE Sample Processing</text>
                        
                        <rect x="30" y="50" width="80" height="60" fill="#fce4ec" stroke="#e91e63" stroke-width="2" rx="5"/>
                        <text x="70" y="75" class="svg-text" text-anchor="middle">Fresh</text>
                        <text x="70" y="95" class="svg-text" text-anchor="middle">Tissue</text>
                        
                        <line x1="110" y1="80" x2="140" y2="80" class="arrow"/>
                        
                        <rect x="140" y="50" width="80" height="60" fill="#fff3e0" stroke="#ff9800" stroke-width="2" rx="5"/>
                        <text x="180" y="75" class="svg-text" text-anchor="middle">Formalin</text>
                        <text x="180" y="95" class="svg-text" text-anchor="middle">Fixation</text>
                        
                        <line x1="220" y1="80" x2="250" y2="80" class="arrow"/>
                        
                        <rect x="250" y="50" width="80" height="60" fill="#e8eaf6" stroke="#3f51b5" stroke-width="2" rx="5"/>
                        <text x="290" y="75" class="svg-text" text-anchor="middle">Paraffin</text>
                        <text x="290" y="95" class="svg-text" text-anchor="middle">Embedding</text>
                        
                        <!-- Spatial Proteomics -->
                        <text x="200" y="150" class="svg-title" text-anchor="middle">Spatial Proteomics Workflow</text>
                        
                        <!-- Tissue section -->
                        <rect x="50" y="180" width="100" height="80" fill="#e8f5e9" stroke="#4caf50" stroke-width="3" rx="5"/>
                        <circle cx="70" cy="200" r="8" fill="#ff5252"/>
                        <circle cx="90" cy="210" r="8" fill="#2196f3"/>
                        <circle cx="110" cy="195" r="8" fill="#ff9800"/>
                        <circle cx="75" cy="230" r="8" fill="#9c27b0"/>
                        <circle cx="120" cy="225" r="8" fill="#4caf50"/>
                        <text x="100" y="270" class="svg-text" text-anchor="middle">Tissue Section</text>
                        
                        <line x1="150" y1="220" x2="185" y2="220" class="arrow"/>
                        
                        <!-- Analysis -->
                        <rect x="185" y="180" width="100" height="80" fill="#e1f5fe" stroke="#03a9f4" stroke-width="2" rx="5"/>
                        <text x="235" y="215" class="svg-text" text-anchor="middle">Laser</text>
                        <text x="235" y="235" class="svg-text" text-anchor="middle">Microdissection</text>
                        <text x="235" y="250" class="svg-text" text-anchor="middle">or MALDI-MSI</text>
                        
                        <line x1="285" y1="220" x2="320" y2="220" class="arrow"/>
                        
                        <!-- Results -->
                        <rect x="320" y="180" width="70" height="80" fill="#f3e5f5" stroke="#9c27b0" stroke-width="2" rx="5"/>
                        <text x="355" y="215" class="svg-text" text-anchor="middle">Spatial</text>
                        <text x="355" y="235" class="svg-text" text-anchor="middle">Protein</text>
                        <text x="355" y="250" class="svg-text" text-anchor="middle">Map</text>
                    </svg>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>Tissue proteomics analyzes protein expression directly in tissue samples, providing crucial information about disease pathology, tumor microenvironment, and spatial protein distribution. This approach is particularly valuable for understanding disease mechanisms and identifying therapeutic targets.</p>
                    
                    <h3>FFPE Sample Analysis</h3>
                    <ul>
                        <li><strong>Clinical standard:</strong> Formalin-Fixed Paraffin-Embedded (FFPE) tissues are routinely archived in hospitals</li>
                        <li><strong>Advantages:</strong> Long-term storage stability, extensive historical archives, linkage to clinical outcomes</li>
                        <li><strong>Challenges:</strong> Protein cross-linking by formalin requires antigen retrieval or specialized protocols</li>
                        <li><strong>Modern solutions:</strong> Heat-induced epitope retrieval (HIER), optimized digestion protocols</li>
                    </ul>
                    
                    <h3>Spatial Proteomics</h3>
                    <ul>
                        <li><strong>MALDI Mass Spectrometry Imaging (MSI):</strong> Direct protein profiling on tissue sections with spatial resolution</li>
                        <li><strong>Laser capture microdissection:</strong> Isolate specific cell populations or regions for targeted analysis</li>
                        <li><strong>Multiplex immunohistochemistry:</strong> Simultaneous detection of multiple proteins with spatial context</li>
                        <li><strong>Applications:</strong> Tumor heterogeneity analysis, immune cell mapping, drug distribution studies</li>
                    </ul>
                    
                    <h3>Disease Pathology Applications</h3>
                    <ul>
                        <li>Differentiation between disease subtypes based on protein signatures</li>
                        <li>Identification of molecular mechanisms underlying pathology</li>
                        <li>Discovery of therapeutic resistance mechanisms</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Detailed Section 4: FDA-Approved Tests -->
        <div class="detailed-section">
            <div class="section-header">
                <span class="section-number">4</span>
                FDA-Approved Tests in Detail
            </div>
            <div class="section-content">
                <div class="diagram">
                    <svg width="400" height="350" viewBox="0 0 400 350">
                        <!-- MALDI-TOF Workflow -->
                        <text x="200" y="25" class="svg-title" text-anchor="middle">MALDI-TOF Bacterial Identification</text>
                        
                        <rect x="30" y="50" width="90" height="60" fill="#fff9c4" stroke="#f57f17" stroke-width="2" rx="5"/>
                        <text x="75" y="75" class="svg-text" text-anchor="middle">Bacterial</text>
                        <text x="75" y="95" class="svg-text" text-anchor="middle">Colony</text>
                        
                        <line x1="120" y1="80" x2="150" y2="80" class="arrow"/>
                        
                        <rect x="150" y="50" width="90" height="60" fill="#e1bee7" stroke="#7b1fa2" stroke-width="2" rx="5"/>
                        <text x="195" y="75" class="svg-text" text-anchor="middle">MALDI</text>
                        <text x="195" y="95" class="svg-text" text-anchor="middle">Plate</text>
                        
                        <line x1="240" y1="80" x2="270" y2="80" class="arrow"/>
                        
                        <rect x="270" y="50" width="90" height="60" fill="#c8e6c9" stroke="#2e7d32" stroke-width="2" rx="5"/>
                        <text x="315" y="75" class="svg-text" text-anchor="middle">Species ID</text>
                        <text x="315" y="95" class="svg-text" text-anchor="middle">in minutes</text>
                        
                        <!-- Validation Pyramid -->
                        <text x="200" y="150" class="svg-title" text-anchor="middle">Clinical Validation Requirements</text>
                        
                        <!-- Pyramid layers -->
                        <polygon points="200,170 120,240 280,240" fill="#ffebee" stroke="#c62828" stroke-width="2"/>
                        <text x="200" y="215" class="svg-text" text-anchor="middle" font-size="11">Analytical Validation</text>
                        
                        <polygon points="200,240 100,290 300,290" fill="#fff3e0" stroke="#e65100" stroke-width="2"/>
                        <text x="200" y="270" class="svg-text" text-anchor="middle" font-size="11">Clinical Validation</text>
                        
                        <polygon points="200,290 80,320 320,320" fill="#e8f5e9" stroke="#1b5e20" stroke-width="2"/>
                        <text x="200" y="310" class="svg-text" text-anchor="middle" font-size="11">Clinical Utility</text>
                    </svg>
                </div>
                <div class="description">
                    <h3>Overview</h3>
                    <p>FDA-approved proteomic tests represent the translation of research discoveries into clinical practice. These tests must meet rigorous regulatory standards for analytical performance, clinical validity, and clinical utility.</p>
                    
                    <h3>MALDI-TOF Bacterial Identification</h3>
                    <ul>
                        <li><strong>Technology:</strong> Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry</li>
                        <li><strong>Principle:</strong> Each bacterial species produces a unique protein/peptide mass spectrum "fingerprint"</li>
                        <li><strong>Clinical impact:</strong> Reduces identification time from days (culture-based) to minutes</li>
                        <li><strong>FDA-cleared systems:</strong> Bruker MALDI Biotyper, bioMérieux VITEK MS</li>
                        <li><strong>Applications:</strong> Routine microbiology, rapid sepsis diagnosis, antimicrobial stewardship</li>
                    </ul>
                    
                    <h3>Targeted Protein Panels</h3>
                    <ul>
                        <li><strong>Multi-marker tests:</strong> Combine multiple proteins for enhanced diagnostic accuracy</li>
                        <li><strong>Examples:</strong> OVA1 (ovarian cancer), Oncotype DX (breast cancer prognosis)</li>
                        <li><strong>Technology platforms:</strong> Immunoassays, mass spectrometry, protein microarrays</li>
                        <li><strong>Advantages:</strong> Higher specificity and sensitivity than single markers</li>
                    </ul>
                    
                    <h3>Clinical Validation Requirements</h3>
                    <ul>
                        <li><strong>Analytical validation:</strong> Accuracy, precision, sensitivity, specificity, reproducibility</li>
                        <li><strong>Clinical validation:</strong> Association with clinical outcome in defined populations</li>
                        <li><strong>Clinical utility:</strong> Demonstration that test results improve patient outcomes</li>
                        <li><strong>Regulatory pathway:</strong> FDA 510(k) clearance, PMA approval, or LDT under CLIA</li>
                        <li><strong>Post-market surveillance:</strong> Ongoing monitoring of test performance</li>
                    </ul>
                    
                    <h3>Emerging Approved Applications</h3>
                    <ul>
                        <li>Mass spectrometry-based newborn screening for metabolic disorders</li>
                        <li>Proteomic classifiers for disease subtyping</li>
                        <li>Therapeutic drug monitoring using LC-MS/MS</li>
                    </ul>
                </div>
            </div>
        </div>

    </div>
</body>
</html>